Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets

v3.21.2
Condensed Balance Sheets - USD ($)
Sep. 30, 2021
Dec. 31, 2020
ASSETS    
Cash $ 789,012 $ 25,000
Prepaid expenses 583,799
Total current assets 1,372,811 25,000
Investments held in Trust Account 174,226,747
Total Assets 175,599,558 25,000
Current liabilities:    
Accounts payable 74,593
Accrued expenses 103,370 1,000
Accrued expenses - related party 20,000
Franchise tax payable 24,034
Accrued offering costs 33,960
Total current liabilities 255,957 1,000
Warrant liability 12,670,500
Total Liabilities 12,926,457 1,000
Commitments and Contingencies
Common stock, $0.0001 par value; 17,250,000 and 0 shares at redemption value at September 30, 2021 and December 31, 2020, respectively 174,225,000
Stockholders’ (Deficit) Equity    
Common stock, $0.0001 par value; 200,000,000 shares authorized; 4,312,500 shares issued and outstanding (excluding 17,250,000 and 0 shares subject to possible redemption) at September 30, 2021 and December 31, 2020 [1] 431 431
Additional paid-in capital 24,569
Accumulated deficit (11,552,330) (1,000)
Total Stockholders’ (Deficit) Equity (11,551,899) 24,000
TOTAL LIABILITIES, COMMON STOCK SUBJECT TO REDEMPTION AND STOCKHOLDERS’ (DEFICIT) EQUITY $ 175,599,558 $ 25,000
[1] Includes up to 562,500 common stock subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriter (see Note 5). The underwriters exercised their over-allotment option in full on July 28, 2021; thus, no shares of common stock remain subject to forfeiture (see Note 6).